GlassScriptPhysician profile
Jennifer P Taylor
NPI 1417171661
$543.89
in general payments reported to CMS, 2019-2025
13 companies · $50.23 in 2025
The $50.23 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $16.31 · 2022: $14.77 · 2023: $22.20 · 2024: $231 · 2025: $50.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299 · Education: $4.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.69 |
| Education | $4.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $131.14 | 2024 | Veozah |
| Abbvie INC. | $110.95 | 2019-2024 | |
| Exeltis, USA INC. | $70.75 | 2023-2025 | Slynd |
| Allergan, INC. | $39.89 | 2019 | |
| Sage Therapeutics, LLC | $36.38 | 2024 | |
| Mylan Pharmaceuticals INC. | $34.37 | 2019-2022 | |
| Duchesnay USA Incorporated | $30.55 | 2019 | |
| Lupin INC. | $18.96 | 2019 | |
| Novo Nordisk INC | $16.61 | 2025 | Wegovy |
| Convatec INC. | $16.31 | 2020 | |
| Roche Diagnostics Corporation | $13.55 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.73 | 2019 | |
| Avanos Medical | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.